Health Institutes of Türkiye (TUSEB)

The Results of TURKOVAC published in VACCINES

Last Added News

TÜSEB Holds Online Briefing and Consultation Meeting with YLSY Scholars

World Breastfeeding Week: A Healthy Start to Life

Prof. Rıfat Atun, Member of the TÜSEB International Scientific Advisory Board, Appointed Dean for Education and Innovation at Harvard T.H. Chan School of Public Health

TÜSEB Hosts Technical Meeting to Advance Türkiye-US Health Partnership

TÜSEB International Scientific Advisory Board Member Prof. Gökhan S. Hotamışlıgil Elected to the U.S. National Academy of Sciences

Strategic Cooperation Step Between TÜSEB and Uzbekistan in Biopharmaceuticals and Health Sciences

A Meeting Was Held with YLSY Scholarship Holders Studying Abroad on Behalf of TÜSEB

Global Burden of Disease Training Program Jointly Organized by Health Institutes of Türkiye (TÜSEB) and Institute for Health Metrics and Evaluation (IHME)

Global Collaboration Against Dengue: International Call for Proposals Launched with TÜSEB’s Contribution

TÜSEB International Scientific Advisory Board Member Prof. Dr. Akgün İnce Named a '2026 Castle Connolly Top Doctor’

ALL NEWS

The results of pre-clinical trials of Inactivated COVID-19 Vaccine TURKOVAC developed in cooperation with Health Institutes of Turkey (TUSEB) and Erciyes University were published in one of the distinguished scientific journals “Vaccines”.

Please click here to see full text of “Development of an Inactivated Vaccine against SARS CoV-2”.

November 3, 2021